Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adequate Therapy of Topiramate in Migraine

NCT01060111 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.

NCT NCT01060111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01060111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adequate Therapy of Topiramate in Migraine
Lead sponsor
Janssen Korea, Ltd., Korea
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2006
Completion date
July 31, 2008
Enrollment
250 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

migraine